Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates.

By P. Caliceti, F. Veronese. Advanced Drug Delivery Reviews, 2003

870 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Nanoparticle PEGylation for imaging and therapy (2011, background): “Immunogenicity has also been reported, but generally less so than the immunogenicity of the NP [142].”
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential (2006, methodology): “Furthermore, the number of ligand molecules exposed on the liposome surface can be increased, improving ligand avidity and degree of uptake.”
PEGylation of therapeutic proteins (2010, background): “These are also the natural clearing mechanisms for large protein molecules with molecular masses above 70 kDa [23].”